共 50 条
- [1] Methylprednisolone versus intravenous immunoglobulins in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS): an open-label, multicentre, randomised trial LANCET CHILD & ADOLESCENT HEALTH, 2023, 7 (04): : 238 - 248
- [2] Methylprednisolone or Intravenous Immunoglobulin in Children with Paediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2 (PIMS-TS)? Indian Pediatrics, 2023, 60 : 571 - 574
- [5] Immunomodulatorytherapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial LANCET CHILD & ADOLESCENT HEALTH, 2024, 8 (03): : 190 - 200
- [7] Paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS): a Brazilian cohort Advances in Rheumatology, 62